Skip to main content
EN ESPAÑOL
  • About Us
  • Local Resources
  • News & Events
  • Our Impact
  • Sign In
  • Understanding
Crohn’s & Colitis
    • Education
      • What is Crohn’s Disease?
      • What is Ulcerative Colitis?
      • Who Gets IBD?
      • IBD vs. IBS
      • Symptoms
      • Diagnosis & Testing
      • Treatment Options
    • Resources
      • Find a Medical Expert
      • IBD Medication Guide
      • GI Tract Guide
      • Financial Assistance Programs
      • Gut Friendly Recipes
      • Restroom Access App
    • About Our Research
      • Clinical Trials
      • Our Initiatives
    • Get Help
      • IBD Help Center
    • abc
      Newly Diagnosed
    • abd
      MyIBD Learning
  • Living with 
Crohn’s & Colitis
    • I need help with...
      • My new diagnosis
      • Affording care
      • Partnering with my doctor
      • Managing a flare
      • Starting a family
      • What should I eat?
      • IBD Help Center
      • MyIBD Learning
    • Health & Wellbeing
      • Managing Treatments
      • Beyond the Gut
      • Pain & Fatigue
      • Diet & Nutrition
      • Ostomy Care
      • Mental & Emotional Health
      • Screenings, Vaccines and More
      • Complications
      • Restroom Access
    • Support
      • Support Groups
      • Peer to Peer Mentoring
      • Camp Oasis for Kids
    • Communities
      • Parents, Kids & Teens
      • Local Chapters
      • Be an Advocate
      • Find an Event
      • Volunteer
  • Research
    • Clinical Programs
      • Quality of Care (QORUS)
      • Adult (SPARC IBD)
      • Children (CAPTURE)
      • Surgery (SIROC)
    • Research Funding
      • Flagship Awards
      • IBD Ventures Funding
      • Translational Research Awards
    • IBD Plexus
      • About IBD Plexus
      • Academic Success
    • Publications
      • Inflammatory Bowel Diseases
      • Crohn's & Colitis 360
      • Under the Microscope
    • lab
      Our Research Impact
    • doc
      Participate in Research
  • Healthcare
Professionals
    • For My Patient
      • Appeal Letters
      • Order Brochures
      • EMR Smart Phrases
      • Template for Section 504 Plan
      • Camp Oasis for Kids
      • IBD Help Center
      • MyIBD Learning
      • Quality of Care IBD Qorus
    • Education
      • IBP Pro Hub (Clinical Hub)
      • Online Modules & CME
      • Diet & Nutrition
      • Nurses & Advanced Practice
Providers
      • For Pharmacists
    • Resources
      • Health Maintenance Checklists
      • Position Papers
      • Downloadable Papers &
Brochures
      • Publications
    • Professional Membership
      • Information
      • Fellow of the Foundation
      • Join/Renew Membership
    • Opportunities
      • Career Development
      • Research Funding
      • Join a Committee
    • Meetings & Programs
      • Crohn’s & Colitis Congress
      • IBD Innovate
      • IBD Pro Programs
Get Involved
EN ESPAÑOL
  • About Us
  • Local Resources
  • News & Events
  • Our Impact
  • Sign In
Get Involved DONATE
    • General Information >>
    • Eligibility >>
    • Study Details >>
    • Contact Information >>

    The Use of Telehealth-Delivered Gut-Directed Hypnotherapy for Managing Gastrointestinal Health

    Published: 06/12/2025

    General Information:

    Sponsor
    Click Here to Learn More »
    Study Objective

    The primary objective of this research is to evaluate specific and non-specific effects of hypnotherapy. 

    The secondary objective is to evaluate the efficacy of group-format gut-directed hypnotherapy delivered via telehealth for managing gastrointestinal health.

    Phase of study
    Other
    ⇧ RETURN TO TOP

    Eligibility:

    Age
    Adult (18+)
    Gender
    Female
    Male
    Disease Type
    Crohn's Disease
    other
    Ulcerative Colitis
    IBD
    Severity
    Mild
    Moderate
    Severe
    Eligibility Criteria

    Inclusion Criteria: 

    Age 18 or older.

    Self-reported gastrointestinal symptoms consistent with disorders of gut-brain interaction. 

    English-speaking

    Willingness to participate in all hypnotherapy sessions & complete all pre- and post-session surveys. 

    Exclusion Criteria: 

    Individuals under 18 years of age.

    Members of vulnerable populations (pregnant women, prisoners, children).

    Individuals with active or a history of severe mental illness (e.g. active psychosis, dissociative disorders).

    Individuals with a history of adverse reactions to hypnosis.

    ⇧ RETURN TO TOP

    Study Details:

    Study description/explanation of participation:

    This study is testing how well Gut-Directed Hypnotherapy and General Hypnotherapy for Relaxation can help with stomach and digestion problems through telehealth group sessions. The study lasts 4 weeks and includes 8 hypnotherapy sessions, each lasting about 1.5 hours. Participants will complete surveys before and after the study, and after each session. In addition, there will be a 20-30 minute online follow-up 3 months after completion of the study to see if the effects were maintained.

    Description of treatment or intervention (mechanism of action): 

    Background:

    Gut-directed hypnotherapy (GDH) was developed in the 1980s by Dr. Peter J. Whorwell, a gastroenterologist in England. He used hypnotherapy to help people with irritable bowel syndrome (IBS) when traditional treatments like special diets, laxatives, and medications weren’t working. Dr. Whorwell believed that hypnotherapy could help calm the brain-gut connection, and early studies showed that hypnosis could improve pain, gut motility, and responses to food.

    The goal of GDH is to help patients enter a relaxed, focused state, similar to a trance, where they are more open to suggestions that may improve both mental and physical health.

    What’s Missing in Current Research:

    Gut-directed hypnotherapy has shown promising results for treating Disorders of Gut-Brain Interaction, which include stomach and gut problems like IBS. However, there are still some important questions that haven’t been fully answered. One such question is whether GDH works well when done in a group format or over telehealth (online). Some early studies suggest it might, but we need more research to be sure. 

    Another question is whether GDH is better than other types of hypnotherapy. We don’t know for sure if the gut-focused part of GDH makes it more effective, or if the benefits come mostly from relaxation that general hypnotherapy provides. This study will help us learn whether GDH works better than general relaxation hypnotherapy.

    Early Results from Other Studies:

    Early research gives us a good reason to be hopeful about gut-directed hypnotherapy. A review of 12 studies shows strong support for doing more research in this area. 

    In one study with people who have Crohn’s disease, 79% of participants said they had a positive experience with GDH over telehealth (Lores et al., 2023). Another study included adults with IBS who used a 42-day digital GDH program called Nerva. In that group, 71% reported their pain decreased by 30%, while only 35% of participants in a control group reported the same. People using GDH also said their quality of life improved more than those who did not use it (Anderson, 2024).

    These results suggest that GDH delivered online could be helpful, but we still need more studies to understand how well it works in group formats and how it compared to general hypnotherapy.

    Patient Participation Requirements:

    Participants will need access to a laptop, headphones, a reliable internet connection, and a quiet, private space to join Zoom sessions. They must also be available on weekday evenings. Participants will complete several surveys: one before the study, one after the study, and one three months later (each taking about 20–30 minutes). After each hypnotherapy session, they will also complete a short survey lasting 5–10 minutes.

    Possible risks and side effects:

    This study is considered very safe and has very few risks, but you might feel a little uncomfortable at times.

    Emotional risks:

    Gut-Directed Hypnotherapy (GDH) is designed to help you relax, but some people may feel frustrated or uncomfortable if they have trouble relaxing. These feelings usually go away quickly. You can stop participating in the study at any time if you feel too uncomfortable.

    Feeling sleepy or unusual:

    Some people may feel sleepy or experience a brief change in awareness during or after hypnosis. This usually fades within minutes. You’ll be reminded to make sure you feel fully alert before driving or doing anything that requires focus.

    Changes in symptoms:

    GDH has helped many people with gut-related symptoms, but it may not work the same for everyone. You might feel better, stay the same, or notice some ups and downs during the study.

    Physical risks:

    There are no serious physical risks, but each session lasts about 1.5 hours. Sitting for that long could be a little uncomfortable, especially if you have back or joint pain.

    Privacy and technology risks:

    Sessions will be held over Zoom using a secure, HIPAA compliant platform. The hypnotherapist will take steps to keep your information private. However, since you're participating from home, it’s your responsibility to join from a quiet and private space where others can’t hear you. If your internet cuts out during a session, the team may not be able to help right away due to the group format. If you can, you’ll be allowed to rejoin the session.

    Group sessions and confidentiality:

    Because this is a group-based study, there’s a small chance that another participant may share something from the session outside of the group. Everyone will be asked and reminded to keep things private, but the research team cannot guarantee that others will do so.

    There are no legal or financial risks. Participation is free, completely voluntary, and non-invasive. Any small risks, such as feeling sleepy, are expected to be short-term and mild.

    ⇧ RETURN TO TOP

    Contact Information:

    Site Locations

    University of Central Florida 4000 Central Florida Blvd #PSY 205 Orlando, Florida 32816
    Sabrina Romero
    561-450-9668
    [email protected]
    Language: English
    Click Here to Learn More »
    ⇧ RETURN TO TOP

    Crohn's & Colitis Foundation

    733 Third Avenue, Suite 510, New York NY 10017

    [email protected]
    • About Us
    • Sign In
    • Our Impact
    • Local Resources
    • Careers
    • News & Events
    • Store
    ©2026 Crohns & Colitis Foundation | The Crohn's & Colitis Foundation is a 501(c)(3) non-profit organization | EIN 13-6193105 Privacy Policy

    By using this website, you agree to our Terms of Use and to our Legal Notice and Privacy Policy. You also agree that any donation complies with Florida SB 700. This bill prohibits donations from “foreign countries of concern.” See our Donor Attestation Statement for more details." It’ll need to be hyperlinked to allow to bring users to our (to be built) Donor Attestation Statement page.

    Charity Watch Top Rated Candid Platinum Transparency BBB Accredited Charity Charity Navigator